Home / insider
Budur Kumar
CHIEF MEDICAL OFFICER
Dr. Budur has served as our Chief Medical Officer since May 2023. Previously, Dr. Budur was the Executive Medical Director at AbbVie Inc., a public biopharmaceuticals company, from August 2015 to February 2022. Prior to this, Dr. Kumar held positions of increasing responsibilities for six years at Takeda Pharmaceutical Company Limited, a global, research and development-driven pharmaceutical company. A nationally recognized expert in Research and Development, he has overseen programs ranging from late discovery, early clinical development to late clinical development, and post-marketing studies. He has experience in progressing small molecules, biologics, drug-device combination through various stages of…
Biography from the company’s latest DEF 14A proxy statement
HRMY price and prints
Full HRMY chartHarmony Biosciences Holdings, Inc. 7 open-market prints by this insider, 9/4/2026 – 9/18/2026. Triangles mark only their Form 4 purchases and sales.
HRMY trades
| Date | Form 4 | Ticker | Side | Shares | Value | 90d | 180d |
|---|---|---|---|---|---|---|---|
| 9/18/2026 | Harmony Biosciences Holdings, Inc · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$8.82BPrice$42.0252w high$42.8652w low$25.90 | SELL | 35,852 | $1.54M | — | — | |
| 9/17/2026 | Harmony Biosciences Holdings, Inc · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$8.82BPrice$42.0252w high$42.8652w low$25.90 | SELL | 800 | $34.4K | — | — | |
| 9/16/2026 | Harmony Biosciences Holdings, Inc · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$8.82BPrice$42.0252w high$42.8652w low$25.90 | SELL | 1,800 | $77.4K | — | — | |
| 9/8/2026 | Harmony Biosciences Holdings, Inc · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$8.82BPrice$42.0252w high$42.8652w low$25.90 | SELL | 4,500 | $190.1K | — | — | |
| 9/8/2026 | Harmony Biosciences Holdings, Inc · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$8.82BPrice$42.0252w high$42.8652w low$25.90 | SELL | 1,000 | $42.8K | — | — | |
| 9/8/2026 | Harmony Biosciences Holdings, Inc · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$8.82BPrice$42.0252w high$42.8652w low$25.90 | SELL | 22,954 | $989.3K | — | — | |
| 9/4/2026 | Harmony Biosciences Holdings, Inc · Pharmaceutical PreparationsIndustryPharmaceutical PreparationsMkt cap (est.)$8.82BPrice$42.0252w high$42.8652w low$25.90 | SELL | 5,500 | $230.9K | — | — |
Chart uses split-adjusted closes from the first print through the latest available bar. Returns use the last close on or before the trade date and the first close on or after 90 and 180 calendar days. Sales are signed so a declining price is a positive result for the seller. Not investment advice.